T1	PROC 29 35	pautas
#1	AnnotatorNotes T1	C0935576; treatment guideline; Therapeutic or Preventive Procedure
T2	CHEM 39 62	suplementos vitamínicos
#2	AnnotatorNotes T2	C0302837; Vitamin supplementation; Pharmacologic Substance
T3	CHEM 84 96	homocisteína
#3	AnnotatorNotes T3	C0019878; homocysteine; Amino Acid, Peptide, or Protein · Biologically Active Substance
T4	PROC 113 125	hemodiálisis
#4	AnnotatorNotes T4	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T5	PROC 127 167	Ensayo clínico prospectivo y randomizado
#5	AnnotatorNotes T5	C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T6	DISO 173 193	hiperhomocisteinemia
#6	AnnotatorNotes T6	C0598608; Hyperhomocysteinemia; Disease or Syndrome
T7	DISO 228 236	urémicos
#7	AnnotatorNotes T7	C0041948; Uremia; Disease or Syndrome
T8	CHEM 434 466	metilentetrahidrofolatoreductasa
#8	AnnotatorNotes T8	C0066357; Methylenetetrahydrofolate reductase (NADPH); Amino Acid, Peptide, or Protein · Enzyme
T9	DISO 263 284	riesgo cardiovascular
#9	AnnotatorNotes T9	C4324389; Cardiovascular Risk; Finding
T10	CHEM 291 314	suplementos vitamínicos
#10	AnnotatorNotes T10	C0302837; Vitamin supplementation; Pharmacologic Substance
T11	PROC 327 350	niveles de homocisteína
#11	AnnotatorNotes T11	C2242817; Homocysteine measurement; Laboratory Procedure
T12	CHEM 338 350	homocisteína
#12	AnnotatorNotes T12	C0019878; homocysteine; Amino Acid, Peptide, or Protein · Biologically Active Substance
T13	PROC 519 530	tratamiento
#13	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	PROC 570 576	pautas
#14	AnnotatorNotes T14	C0935576; treatment guideline; Therapeutic or Preventive Procedure
T15	CHEM 580 603	suplementos vitamínicos
#15	AnnotatorNotes T15	C0302837; Vitamin supplementation; Pharmacologic Substance
T16	PROC 647 658	tratamiento
#16	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	PROC 674 721	Estudio prospectivo, randomizado, a doble ciego
#17	AnnotatorNotes T17	C0033522; Prospective Studies; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
T18	PROC 745 757	hemodiálisis
#18	AnnotatorNotes T18	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T19	CHEM 1820 1825	MTHFR
#19	AnnotatorNotes T19	C0066357; Methylenetetrahydrofolate reductase (NADPH); Amino Acid, Peptide, or Protein · Enzyme
T20	CHEM 826 838	ácido fólico
#20	AnnotatorNotes T20	C0016410; folic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T21	CHEM 846 857	vitamina B6
#21	AnnotatorNotes T21	C0087162; vitamin B6; Organic Chemical · Pharmacologic Substance · Vitamin
T22	CHEM 860 863	B12
#22	AnnotatorNotes T22	C0020316; hydroxocobalamin; Organic Chemical · Pharmacologic Substance · Vitamin | C0042845; vitamin B12; Organic Chemical · Pharmacologic Substance · Vitamin
T23	PROC 996 1011	valores de Hcys
#23	AnnotatorNotes T23	C2242817; Homocysteine measurement; Laboratory Procedure
T24	PROC 1159 1174	niveles de Hcys
#24	AnnotatorNotes T24	C2242817; Homocysteine measurement; Laboratory Procedure
T25	CHEM 2075 2079	Hcys
#25	AnnotatorNotes T25	C0019878; homocysteine; Amino Acid, Peptide, or Protein · Biologically Active Substance
T26	PROC 1293 1299	pautas
#26	AnnotatorNotes T26	C0935576; treatment guideline; Therapeutic or Preventive Procedure
T27	PROC 1341 1345	Hcys
#27	AnnotatorNotes T27	C2242817; Homocysteine measurement; Laboratory Procedure
T28	PROC 1456 1471	niveles de Hcys
#28	AnnotatorNotes T28	C2242817; Homocysteine measurement; Laboratory Procedure
T29	PROC 1523 1534	tratamiento
#29	AnnotatorNotes T29	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T30	PROC 1924 1930	pautas
#30	AnnotatorNotes T30	C0935576; treatment guideline; Therapeutic or Preventive Procedure
T31	PROC 1949 1961	hemodiálisis
#31	AnnotatorNotes T31	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T32	DISO 1980 2000	déficits vitamínicos
#32	AnnotatorNotes T32	C1510471; Vitamin Deficiency; Disease or Syndrome
T33	PROC 2064 2079	niveles de Hcys
#33	AnnotatorNotes T33	C2242817; Homocysteine measurement; Laboratory Procedure
T34	ANAT 2264 2278	cardiovascular
#34	AnnotatorNotes T34	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T35	ANAT 270 284	cardiovascular
#35	AnnotatorNotes T35	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T36	PROC 543 562	Conocer la eficacia
#36	AnnotatorNotes T36	C1707887; Efficacy Study; Research Activity
T37	CHEM 1007 1011	Hcys
#37	AnnotatorNotes T37	C0019878; homocysteine; Amino Acid, Peptide, or Protein · Biologically Active Substance
T38	CHEM 1989 2000	vitamínicos
#38	AnnotatorNotes T38	C0042890; Vitamins; Organic Chemical · Pharmacologic Substance · Vitamin
T39	PROC 73 96	niveles de homocisteína
#39	AnnotatorNotes T39	C2242817; Homocysteine measurement; Laboratory Procedure
T40	PROC 352 356	Hcys
#40	AnnotatorNotes T40	C2242817; Homocysteine measurement; Laboratory Procedure
T41	CHEM 468 473	MTHFR
#41	AnnotatorNotes T41	C0066357; Methylenetetrahydrofolate reductase (NADPH); Amino Acid, Peptide, or Protein · Enzyme
T42	CHEM 625 629	Hcys
#42	AnnotatorNotes T42	C0019878; homocysteine; Amino Acid, Peptide, or Protein · Biologically Active Substance
T43	PROC 614 629	niveles de Hcys
#43	AnnotatorNotes T43	C2242817; Homocysteine measurement; Laboratory Procedure
T44	PROC 758 774	se aleatorizaron
#44	AnnotatorNotes T44	C0034656; Randomization; Research Activity
T45	CHEM 1170 1174	Hcys
#45	AnnotatorNotes T45	C0019878; homocysteine; Amino Acid, Peptide, or Protein · Biologically Active Substance
T46	CHEM 1467 1471	Hcys
#46	AnnotatorNotes T46	C0019878; homocysteine; Amino Acid, Peptide, or Protein · Biologically Active Substance
T47	PROC 1677 1681	Hcys
#47	AnnotatorNotes T47	C2242817; Homocysteine measurement; Laboratory Procedure
T48	PROC 1725 1729	Hcys
#48	AnnotatorNotes T48	C2242817; Homocysteine measurement; Laboratory Procedure
T49	LIVB 100 109	pacientes
#49	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	LIVB 218 227	pacientes
#50	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T53	PROC 419 427	genotipo
#51	AnnotatorNotes T53	C1285573; Genotype determination; Laboratory Procedure
T55	Duration 635 643	12 meses
T56	LIVB 732 741	pacientes
#52	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	Dose 886 892	0,4 mg
T58	Frequency 893 900	diarios
T59	Dose 967 971	1 mg
T60	Frequency 972 979	diarios
T61	LIVB 1033 1046	grupo control
#53	AnnotatorNotes T61	C0009932; Control Groups; Group
T62	LIVB 1094 1103	pacientes
#54	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	LIVB 1203 1212	pacientes
#55	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	LIVB 1223 1236	grupo control
#56	AnnotatorNotes T64	C0009932; Control Groups; Group
T65	LIVB 1378 1387	pacientes
#57	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	Duration 1516 1519	mes
T67	Duration 1591 1598	6 meses
T68	Duration 1641 1653	los 12 meses
T69	PHYS 1801 1813	polimorfismo
#58	AnnotatorNotes T69	C0032529; Genetic Polymorphism; Genetic Function
T71	Neg_cue 1969 1971	no
T51	LIVB 1120 1129	controles
#59	AnnotatorNotes T51	C0009932; Control Groups; Group
T52	DISO 2247 2278	morbi-mortalidad cardiovascular
A1	Assertion T32 Negated
R1	Negation Arg1:T71 Arg2:T32	
T54	Neg_cue 2106 2108	no
T70	CONC 2117 2125	ventajas
A2	Assertion T70 Negated
R2	Negation Arg1:T54 Arg2:T70	
T72	Quantifier_or_Qualifier 2126 2137	adicionales
A3	Assertion T72 Negated
R3	Has_Quantifier_or_Qualifier Arg1:T70 Arg2:T72	
R4	Negation Arg1:T54 Arg2:T72	
T73	CONC 1829 1837	modificó
A4	Assertion T73 Negated
T74	Neg_cue 1826 1828	no
R5	Negation Arg1:T74 Arg2:T73	
T75	Quantifier_or_Qualifier 370 383	bien definida
A5	Assertion T75 Negated
T76	Neg_cue 359 361	no
R6	Negation Arg1:T76 Arg2:T75	
T77	CONC 387 392	dosis
#60	AnnotatorNotes T77	C0178602; Dosage; Quantitative Concept
R7	Has_Quantifier_or_Qualifier Arg1:T77 Arg2:T75	
R8	Experiences Arg1:T49 Arg2:T4	
R9	Experiences Arg1:T49 Arg2:T39	
R10	Experiences Arg1:T49 Arg2:T2	
R13	Experiences Arg1:T50 Arg2:T6	
R14	Overlap Arg1:T6 Arg2:T7	
R15	Experiences Arg1:T50 Arg2:T7	
R16	Location_of Arg1:T35 Arg2:T9	
R17	Experiences Arg1:T50 Arg2:T9	
R18	Overlap Arg1:T7 Arg2:T9	
R19	Overlap Arg1:T6 Arg2:T9	
R20	Before Arg1:T10 Arg2:T78	
T79	Observation 506 530	respuesta al tratamiento
#62	AnnotatorNotes T79	C1319171; Medication response; Finding
R23	Overlap Arg1:T79 Arg2:T13	
R25	After Arg1:T43 Arg2:T16	
R26	Has_Duration_or_Interval Arg1:T16 Arg2:T55	
R27	Used_for Arg1:T15 Arg2:T16	
R28	Experiences Arg1:T56 Arg2:T18	
R29	Before Arg1:T44 Arg2:T20	
R30	Combined_with Arg1:T20 Arg2:T21	
R31	Combined_with Arg1:T21 Arg2:T22	
R33	Has_Frequency Arg1:T22 Arg2:T58	
R34	Has_Frequency Arg1:T21 Arg2:T58	
R35	Has_Frequency Arg1:T20 Arg2:T58	
R36	Has_Dose_or_Strength Arg1:T20 Arg2:T57	
R32	Has_Dose_or_Strength Arg1:T22 Arg2:T59	
R37	Has_Frequency Arg1:T22 Arg2:T60	
T80	Dose 961 964;969 971	100 mg
R38	Has_Dose_or_Strength Arg1:T21 Arg2:T80	
T81	Dose 957 959;969 971	15 mg
R39	Has_Dose_or_Strength Arg1:T20 Arg2:T81	
T82	Dose 878 879;890 892	5 mg
R40	Has_Dose_or_Strength Arg1:T20 Arg2:T82	
T83	Dose 881 883;890 892	10 mg
R41	Has_Dose_or_Strength Arg1:T21 Arg2:T83	
R42	Experiences Arg1:T61 Arg2:T23	
R43	Experiences Arg1:T56 Arg2:T20	
R44	Experiences Arg1:T51 Arg2:T24	
R45	Experiences Arg1:T62 Arg2:T24	
R46	Experiences Arg1:T63 Arg2:T24	
R47	Experiences Arg1:T64 Arg2:T24	
T84	Observation 1330 1345	reducir la Hcys
#63	AnnotatorNotes T84	C0877299; Blood homocysteine decreased; Finding (?) | C0877683; Serum homocysteine decreased; Finding (?)
R48	Experiences Arg1:T65 Arg2:T27	
R50	Experiences Arg1:T65 Arg2:T84	
R51	Causes Arg1:T26 Arg2:T84	
T85	Result_or_Value 1388 1412	normalizaron sus niveles
#64	AnnotatorNotes T85	C0877301; Blood homocysteine normal; Finding (?) | C0877582; Serum homocysteine normal; Finding (?)
R52	Experiences Arg1:T65 Arg2:T85	
R53	Causes Arg1:T26 Arg2:T85	
R54	Before Arg1:T84 Arg2:T85	
T86	CONC 1416 1436	finalizar el estudio
#65	AnnotatorNotes T86	C2983670; Study End Date; Temporal Concept
R55	Overlap Arg1:T85 Arg2:T86	
R56	Overlap Arg1:T27 Arg2:T86	
T87	Observation 1456 1498	niveles de Hcys experimentaron un descenso
R57	After Arg1:T87 Arg2:T66	
R58	Causes Arg1:T29 Arg2:T87	
R60	Has_Duration_or_Interval Arg1:T29 Arg2:T66	
T88	Observation 1565 1573	descenso
#66	AnnotatorNotes T88	C0877299; Blood homocysteine decreased; Finding (?) | C0877683; Serum homocysteine decreased; Finding (?)
R61	After Arg1:T88 Arg2:T67	
R62	After Arg1:T88 Arg2:T68	
T89	Observation 1665 1681	descenso de Hcys
#67	AnnotatorNotes T89	C0877299; Blood homocysteine decreased; Finding (?) | C0877683; Serum homocysteine decreased; Finding (?)
T90	CONC 1696 1711	niveles basales
#68	AnnotatorNotes T90	C1442488; Baseline; Quantitative Concept
T91	Observation 1860 1881	respuesta terapéutica
#69	AnnotatorNotes T91	C1319171; Medication response; Finding
R66	Overlap Arg1:T19 Arg2:T91	
R67	Overlap Arg1:T69 Arg2:T91	
T92	Food 2007 2018	suplementos
#70	AnnotatorNotes T92	C0242295; Dietary Supplements; Food
T93	Observation 2019 2026;2060 2079	reducen los niveles de Hcys
#71	AnnotatorNotes T93	C0877299; Blood homocysteine decreased; Finding (?) | C0877683; Serum homocysteine decreased; Finding (?)
R70	Causes Arg1:T92 Arg2:T93	
R72	Location_of Arg1:T34 Arg2:T52	
T94	Observation 2193 2201	descenso
#72	AnnotatorNotes T94	C0877299; Blood homocysteine decreased; Finding (?) | C0877683; Serum homocysteine decreased; Finding (?)
R73	Before Arg1:T94 Arg2:T52	
R74	Used_for Arg1:T15 Arg2:T14	
R75	Used_for Arg1:T2 Arg2:T1	
T95	Quantifier_or_Qualifier 1838 1856	significativamente
A6	Assertion T95 Negated
#73	AnnotatorNotes T95	C0237881; Statistical Significance; Quantitative Concept
R76	Has_Quantifier_or_Qualifier Arg1:T73 Arg2:T95	
R77	Negation Arg1:T74 Arg2:T95	
#61	AnnotatorNotes T87	C0877299; Blood homocysteine decreased; Finding (?) | C0877683; Serum homocysteine decreased; Finding (?)
T78	Observation 315 357	reducen los niveles de homocisteína (Hcys)
#74	AnnotatorNotes T78	C0877299; Blood homocysteine decreased; Finding (?) | C0877683; Serum homocysteine decreased; Finding (?)
R11	Used_for Arg1:T77 Arg2:T10	
R12	Overlap Arg1:T43 Arg2:T55	
R21	Has_Frequency Arg1:T20 Arg2:T60	
R22	Has_Frequency Arg1:T21 Arg2:T60	
#75	AnnotatorNotes T73	C0443172; Changed status; Quantitative Concept
#76	AnnotatorNotes T72	C1524062; Additional; Functional Concept
#77	AnnotatorNotes T75	C0442825; Well defined; Qualitative Concept
A7	Experiencer T49 Patient
A8	Experiencer T50 Patient
A9	Experiencer T56 Patient
A10	Experiencer T61 Patient
A11	Experiencer T62 Patient
A12	Experiencer T51 Patient
A13	Experiencer T63 Patient
A14	Experiencer T64 Patient
A15	Experiencer T65 Patient
R24	Has_Result_or_Value Arg1:T47 Arg2:T89	
R49	Has_Result_or_Value Arg1:T28 Arg2:T87	
R59	Has_Result_or_Value Arg1:T11 Arg2:T78	
R63	Has_Result_or_Value Arg1:T40 Arg2:T78	
R64	Has_Result_or_Value Arg1:T27 Arg2:T84	
R65	Has_Result_or_Value Arg1:T27 Arg2:T85	
R68	Has_Result_or_Value Arg1:T33 Arg2:T93	
